Treatment Strategy for Infantile Hemangiomas: From the Perspective of A Clinical Dermatologist

Abstract

Infantile hemangioma (IH) is a self-resolving tumor. However, some patients with IH require revision surgery due to the presence of residual lesions after regression. Our clinical therapeutic strategy for IH involves aggressive interventions using a long pulsed dye laser (595 nm) (including a cooling device with a variable pulse width) to reduce redness, oral propranolol administration, or a combination of both methods. The early intervention strategy used at our clinic eliminates the plaque- and mass-type IH in children aged less than 1 and 2 years, respectively. Beginning treatment at an early stage of IH seems to be important to suppress the growth of the tumor.